StableStock 🐳(@StableStock):AI drug discovery may be finding its real scaling law. 🧬 As Claude and other frontier models move deeper into biology, the bottleneck is shifting from model capability to proprietary biological data and real-world feedback. That puts companies with unique data assets in focus. $TEM, for example, has built 500+ PB of molecular and clinical data across 45M+ de-identified patient journeys. The next AI drug race may be less about who has the biggest model — and more about who can build the fastest data → prediction → validation → feedback loop. Trade $TEM on StableStock: → https://t.co/jxxhasERDk #AIDrugDiscovery #Biotech #TEM Not investment advice. For informational purposes only.

2026.09.21 09:04

AI drug discovery may be finding its real scaling law. 🧬 As Claude and other frontier models move deeper into biology, the bottleneck is shifting from model capability to proprietary biological data and real-world feedback. That puts companies with unique data assets in focus. $TEM, for example, has built 500+ PB of molecular and clinical data across 45M+ de-identified patient journeys. The next AI drug race may be less about who has the biggest model — and more about who can build the fastest data → prediction → validation → feedback loop. Trade $TEM on StableStock: → #AIDrugDiscovery# #Biotech# #TEM# Not investment advice. For informational purposes only.

显示更多